RE:RE: 1 share traded..and the wide spread of 10cents shows there is a high degree of uncertainty so both seller and buyer need to be enticed at either end instead of a liquid market with a lot of depth creating a very tight spread so you can transact. It's all about lack of information with a dwindling and very small audience. Once again, the upside to it would be IF there is positive info, it will work the opposite way. Maybe they can attract an audience, transactions go up, spreads diminish, share rises. But they need something positive first.
Seems we'll get dosage, safety info in brief form, a possible conferece poster later, and a larger push in to the basket trial. But they should at a minimum lay out to the investors what the plan now looks like, what the regulatory strategy is, the PPD/Clinic recruiting strategy is, etc... There's just still so much they could educate the market about but sounds like they could care less about doing so if they just release "We hit MTD and will use 300mg as RP2D. No SAEs there. On to basket trial. More later." That would be a bigtime mistake. Start building the audience now. Forget about saving things for a conference to win personal accolades. We're talking the fair valuation of your company here, not scoring points in the oncology egghead world.
SPCEO1 wrote: Sad and incomprehensible.
SS1316 wrote: I'm showing That as of 10:12 am EST only 1 share has been traded... sad